Infants aged 2 years or younger with bronchiolitis faced an increased risk for hospitalization due to air pollution, with a meta-analysis indicating a positive association between exposure to elevated ...
Nirsevimab implementation in Catalonia, Spain, was associated with a 44% reduction in emergency department (ED) visits for bronchiolitis in infants younger than 6 months and a 48% reduction in ...
Bronchiolitis remains a leading cause of hospitalisation among infants and young children, prompting continuous efforts to optimise management strategies. Recent clinical approaches focus on ...
As temperatures start to drop, doctors are seeing more children with respiratory infections, particularly RSV, or Respiratory Syncytial Virus. Pediatrician Dr. José Rentería Alvarez explains that RSV ...
Every parent wants to keep their baby safe — bundled against the cold, buckled in the car seat, and protected from illness.
According to experts, RSV is the leading cause of lower respiratory tract infections such as bronchiolitis and pneumonia that ...
My 13 month old has his first episode of bronchiolitis at 5 weeks old and we spent 8 day in hospital. Since then he has ...
Nirsevimab significantly reduced respiratory syncytial virus (RSV)–associated hospitalizations in infants during the 2024-2025 season, consistent with previous findings. The study used a large dataset ...
As RSV continues to pose a year-round threat, especially in tropical climates like Việt Nam’s, proactive immunisation ...
Today, the World Health Organization (WHO) published its first-ever position paper on immunization products to protect infants against respiratory syncytial virus (RSV) – the leading cause of acute ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback